Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.
-
FDA-Cleared AI Software Targets Streak Artifacts in Cone-Beam CT
The CleaRecon DL software reportedly removes streak artifacts that can occur with the use of cone-beam computed tomography (CBCT) during interventional radiology procedures.
-
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
In a recent interview, C. Alberto Morales, M.D., discussed the impact of advances with CTA imaging and AI, and a shifting emphasis in cardiac risk stratification from stenosis to plaque burden.
-
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for cases > CAD-RADS 4A.
-
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
-
Can Radiomic Parenchymal Phenotypes Derived from Mammography Enhance Risk Stratification for Breast Cancer?
Emerging research suggests that radiomic breast texture features extracted from full-field digital mammography may bolster prognostic assessments of invasive breast cancer risk beyond traditional risk factors.
-
FDA Expands Approval of Cardiac Ultrasound Imaging Agent for Pediatric Patients
The only ultrasound enhancing agent that does not contain polyethylene glycol, Optison may now be utilized to enhance echocardiogram assessment of ventricular function in pediatric patients.
-
FDA Clears New Interventional X-Ray Platform from United Imaging
Employing intelligent robotics and enhanced low-dose image quality, the uAngio AVIVA X-ray system also offers hands-free image review and movement.
-
Mammography Study Shows Key Findings with AI in DBT Screening
The use of AI software for digital breast tomosynthesis (DBT) facilitated a higher cancer detection rate and over double the PPV for exams with abnormal interpretation, according to a newly published study.